Andrew Witty, the firm's chief executive, said procedures for compliance, marketing and selling had been changed at GSK's US unit.
"We have learnt from the mistakes that were made," Mr Witty said. "When necessary, we have removed employees who have engaged in misconduct."
Hopefully they will after this $3bn fine!
I don't buy into this ''Big Pharma'' nonsense that is often talked about on diabetes forums and blogs, there's mistakes made and corruption in all industries and it's up to the regulators and governments to bring them to account. I've seen what a difference drugs can make at saving people's lives having been in intensive care with both of my parents and other family members....therefore I'm always grateful that money and research is still ongoing into finding better treatment and cures for condition and illnesses that rob us of our loved ones or shorten their lives.